16. Segment and geographic information

Our business is strategically aligned into three reportable segments: Medical Imaging, Ultrasound, and Security and Detection. Our business segments are described as follows:

•

Medical Imaging primarily includes systems and subsystems for CT and MRI medical imaging equipment as well as state-of-the-art, selenium-based detectors for screening of breast cancer and other diagnostic applications in mammography.

•

Ultrasound includes ultrasound systems and transducers primarily used in the urology, surgery, EMED and Anesthesia markets.

•

Security and Detection includes advanced threat detecting CT systems utilizing our expertise in advanced imaging technology, primarily used in the checked baggage screening at airports worldwide.

The table below presents information about our reportable segments:

	For the Year ended
	July 31,
(in millions)	2017			2016			2015
Product revenue:
Medical Imaging	$	269.2		$	285.8		$	288.6
Ultrasound		148.0			160.8			163.6
Security and Detection		67.0			56.1			79.0
Total product revenue	$	484.2		$	502.7		$	531.2
Engineering revenue:
Medical Imaging	$	5.0		$	3.4		$	4.0
Ultrasound		(1.1	)		2.4			2.6
Security and Detection		(1.7	)		0.3			2.5
Total engineering revenue	$	2.2		$	6.1		$	9.1
Net revenue:
Medical Imaging	$	274.2		$	289.2		$	292.6
Ultrasound		146.9			163.2			166.2
Security and Detection		65.3			56.4			81.5
Total net revenue	$	486.4		$	508.8		$	540.3
Income (loss) from operations:
Medical Imaging (A)	$	38.0		$	38.6		$	37.9
Ultrasound (B)		(108.0	)		(18.8	)		(7.9	)
Security and Detection (C )		3.2			5.4			10.6
Total (loss) income from operations		(66.8	)		25.2			40.6
Total other income (loss), net		0.50			(4.9	)		0.4
(Loss) income before income taxes	$	(66.3	)	$	20.3		$	41.0

	As of		As of
	July 31,		July 31,
(in millions)	2017		2016
Identifiable total assets by segment:
Medical Imaging	$	169.1	$	191.1
Ultrasound		133.6		152.5
Security and Detection		36.0		49.8
Total reportable segment assets		338.7		393.4
Corporate assets (D)		197.0		165.6
Total identifiable assets	$	535.7	$	559.0

(A)	Includes restructuring charges of $1.4 million, $6.0 million and $(0.2) million for fiscal years 2017, 2016 and 2015, respectively.

(B)	Includes restructuring charges of $5.5 million, $1.9 million and $(0.1)million for fiscal year 2017, 2016 and 2015, respectively.

Includes in fiscal 2017 (i) a $16.4 million impairment charge in connection with the goodwill associated with our Oncura reporting unit, (ii) an impairment charge of $55.2 million in connection with the goodwill associated with our Ultrasound reporting unit, (iii) a write-off of technology of $8.1 million in connection with PocketSonics, (iv) a write-off of customer relationships of $2.4 million and trade names of $0.8 million in connection with Oncura, (v) a $0.2 million asset impairment charge, (vi) a decrease in contingent consideration of $10.2 million related to Oncura.

Includes a $10.1 million and $1.0 million charge for the BK Medical matter for fiscal year 2016 and 2015, respectively.

(C)	Includes restructuring charges of $0.3 million, $1.7 million and $(0.1) million for fiscal year 2017, 2016 and 2015, respectively.

Includes in fiscal 2017 (i) a write-off of developed technology of $0.5 million and trade name of $0.1 million in connection with Pathfinder in fiscal 2017, (ii) a $0.8 million asset impairment charge.

(D)	Includes cash, cash equivalents and marketable securities of $135.2 million as of July 31, 2017. Includes cash and cash equivalents of $97.3 million as of July 31, 2016.

Revenues are attributed to countries based on the location of our customers. For OEM sales, our customer location may differ from the location where the ultimate completed systems are sold by the OEM into the market.

Information regarding share-based compensation and depreciation and amortization by segment for the fiscal years 2017, 2016 and 2015 are as follows:

	For the Year ended
	July 31,
(in millions)	2017		2016		2015
Share-based compensation expense:
Medical Imaging	$	5.3	$	3.9	$	4.9
Ultrasound		2.5		2.6		3.2
Security and Detection		1.6		2.3		2.8
Total share-based compensation expense	$	9.4	$	8.8	$	10.9
Depreciation and amortization:
Medical Imaging	$	10.8	$	11.3	$	11.1
Ultrasound		10.5		10.4		10.5
Security and Detection		1.7		1.8		1.7
Total depreciation and amortization	$	23.0	$	23.5	$	23.3

Information regarding geographic areas for fiscal years 2017, 2016 and 2015 are as follows:

	For the Year ended
	July 31,
(in millions)	2017		2016		2015
Net Revenue:
United States	$	183.5	$	192.3	$	215.3
China		67.4		66.7		51.1
Germany		75.1		68.5		60.2
Netherlands		51.6		54.9		60.4
Other		108.8		126.4		153.3
Total net revenue	$	486.4	$	508.8	$	540.3

	For the Year ended
	July 31,
(in millions)	2017		2016		2015
Property, plant and equipment, net:
United States	$	56.2	$	64.1	$	63.7
Denmark		18.5		16.4		15.6
China		20.4		20.4		19.6
Other (A)		7.6		6.9		7.4
Total property, plant and equipment, net	$	102.7	$	107.8	$	106.3

(A)	– Other property, plant and equipment are primarily in Canada.